APA (7th ed.) Citation

Suekane, S., Noguchi, M., Moriya, F., Sasada, T., Yamada, A., Itoh, K., & Matsuoka, K. (2011). 652 A PHASE II STUDY OF PERSONALIZED PEPTIDE VACCINATION FOR ADVANCED UROTHELIAL CARCINOMA PATIENTS WHO FAILED STANDARD TREATMENT. European Urology Supplements, 10(2), 210. https://doi.org/10.1016/S1569-9056(11)60641-6

Chicago Style (17th ed.) Citation

Suekane, S., M. Noguchi, F. Moriya, T. Sasada, A. Yamada, K. Itoh, and K. Matsuoka. "652 A PHASE II STUDY OF PERSONALIZED PEPTIDE VACCINATION FOR ADVANCED UROTHELIAL CARCINOMA PATIENTS WHO FAILED STANDARD TREATMENT." European Urology Supplements 10, no. 2 (2011): 210. https://doi.org/10.1016/S1569-9056(11)60641-6.

MLA (9th ed.) Citation

Suekane, S., et al. "652 A PHASE II STUDY OF PERSONALIZED PEPTIDE VACCINATION FOR ADVANCED UROTHELIAL CARCINOMA PATIENTS WHO FAILED STANDARD TREATMENT." European Urology Supplements, vol. 10, no. 2, 2011, p. 210, https://doi.org/10.1016/S1569-9056(11)60641-6.